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INTRODUCTION 
 
 DELIBERATE Self harm48 is an important problem in the 
developing world. Ingestion of yellow oleander seeds in Thanjavur 
district is very common due to its easy availability. It is being consumed 
more by the younger age group people. 
  Cardiac  glycosides in the seeds cause vomiting, palpitation, 
cardiac arrythmias affecting the sinus and AV nodes and thereby causing 
mortality. 
 It was decided to study the yellow oleander poisoning in our place 
regarding the clinical profile factors deciding the mortality and 
modification of which would improve the prognosis in our patients. 
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OLEANDER IN VARIOUS SYSTEMS OF  
MEDICINE 
Oleander, One of the common plants found abundantly itself in 
South India, is believed to have its origin in India70. It is also found in 
Tropical America Southern United States Hawaii and Srilanka. 
Charaka (1000 BC) a pioneer in Ayurvedic medicine and 
Sushrutha (800 BC) the ancient surgeon have made references in their 
respective treatises about this plant. 
According to literature in ancient Indian medicine including 
AYURVEDIC, SIDDHA, UNANI and OTHER INDIGENOUS 
SYSTEMS OF MEDICINE Oleander has been used as a medicinal plant 
to treat various disease conditions. 
USAGE IN AYURVEDIC SYSTEM OF MEDICINE 
Oleander plant was known in ancient India since Vedic age. 
Valmiki’s Ramayana, the ancient epic, mentions about this plant71. 
Oleander was used as an external application for many skin 
conditions, and also as an internal medicament for dropsy. Rheumatism 
was treated with a mixture of Oleander leaves with curd10. Other uses 
were as an antiseptic and treatment for chest disease with cough56. It was 
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used for anal fissure and hemorrhoids70. The whole fruit was used as an 
abortifacient30,47,65,66. We find its mention about usage as a purgative10,47, 
emetic47 and anti malarial in various references. It was used in the 
treatment of periodic fever and ureteric stone10,64. 
 
USAGE IN  ‘SIDDHA SYSTEM OF MEDICINE’ 
In siddha system of medicine various preparations from yellow 
Oleander had been tried for many conditions51. 
This included fever, skin disorders, leprosy, anorexia, polydipsia, 
impetigo, Syphilis, Furunculosis and inflammatory disorders. A few 
drops of root oil mixed with gingelly oil had been used to treat 
toothache47. It was used as a germicidal also. 
USAGE IN  ‘UNANI  SYSTEM OF MEDICINE’ 
Yellow Oleander   was widely quoted in Unani system of 
medicine. 
Paste made from the leaves was used in skin disorders, powder of 
the leaves have been tried externally for bruises and superficial wounds70. 
Syphilis and leprosy were treated by an extract from roots and leaves10. 
Paste of the root had been used as aphrodisic47. It was applied externally 
over the male sex organs to correct sexual disability and to improve 
virility. 
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USAGE IN  ‘OTHER  SYSTEM OF INDIAN 
MEDICINE’ 
In other systems of Indian medicine like traditional systems, 
religious systems and community systems, recipe from yellow Oleander 
was used to treat parasitic infestation, leprosy, itching of breast, 
improvement of vision, toothache and wound dressing, urethral discharge 
piles, leucoderma and bronchitis. The roots were made into plaster and 
applied over the tumour12.  It was used in the treatment of heart failure 
and atrial fibrillation in 1930’s. 
FOR SMOKING 
 Oleander leaves were used for smoking but certain quote excess 
smoke will be poison70,28,56. 
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 OLEANDER POISONING – A  
 HISTORICAL REVIEW 
    
OLEANDER POISONING – A 
HISTORICAL REVIEW 
Oleander plant was known since ancient times, finds mention in 
CHARAKA SAMHITHA  under 30-40 different names in Sanskrit 
language70.  
The name thevetia was given in honour to Mr.Andre Thevit  who 
travelled extensively in South America during 16th century and who has 
written extensively about this plant70. 
Some feel PERU  as an original place of Oleander and hence 
Thevetia Peruviana64. Various names of yellow Oleander are EXILE, 
CEREBRA THEVETIA, THEVETIA NERIFOLIA, PILA 
KANER47,1 ,68. 
All parts of the oleander plant including smoke from burning 
cuttings and water in which the flower is placed are poisonous21,28. 
The kernels of seeds43,47 ,30 are eight times more poisonous than 
the leaves followed by latex43,69 of the plant. Compared to other parts 
flower, bark, root and stem are less poisonous. 
It was used for procuring criminal abortion5,50 ,56 ,65 ,66, Suicidal 
and homicidal51 ,61 purpose, love philter, poisoning cattle9,56 , with the 
paste concealed in corn  or chapathi. 
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These names include Ashwaghna, Ashwaha, Ahswadya and 
Aswantak means killer or enemy of horse10. 
Karavira is an another name in which kara means a sword 
used in battles36 ,. 
Shatakundu meaning shata as hundred and kundu a hammer brings 
out its dangerous effects clearly70. 
 Other names used were Viraka meaning a very potent fierce 
nature, Lakuda meaning a weapon made of stick, Rakthapuspha  meaning 
a blood flower depicts its toxic or poisonous nature. 
From the above names we clearly understand that different parts of 
Oleander plant were used or rather abused since ancient times because of 
its Lethal qualities. 
Apart from its role as a cattle poison, the fruit and kernel were used 
to kill fish and insect56. 
Arrows were poisoned with Oleander extract by South American 
and East African Tribes. 
Pigs and Jackals were poisoned with Oleander extract by Mundas a 
Himalayan Tribes. 
Reports about numerous deaths from Oleander branches being used 
as a food skewers, from Oleander smoke and from Oleander flower were 
of historical interest as well as present and future interest28. 
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BOTANICAL DETAILS 
Oleander is being cultivated and scattered all over India. Thevetia 
Nerifolia Juss is an ornamental plant with cosmopolitan distribution. 
It grows as a hedge plant or erect brush or as a small tree47,50. It 
grows quickly and becomes a wild plant covering a large area. It grows 
quickly from seeds and cutting transplants well and has a tendency to 
ensure drought and frost to some extent24,57. 
PLANT CLASSIFICATION44  
   CLASS   - Dicotyle donae 
   SUB-CLASS  - Gamopetalae 
   SERIES   - Bicarpellatae 
   COHORT   - Gentianales 
   FAMILY   - Apocyanaceae 
SHRUB OR TREE 
 Looking attractive and ever blooming, this small tree grows to a 
height of 12-15 feet and 8-10 inches thickness. Complete naturalization 
has occurred in India.  This is shown in photograph 1. 
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PARTS OF THE PLANT 
STEM 
 It is solid, cylindrical, erect and branched and has a milky latex4,22. 
This is shown in photograph 2. 
 
LEAVES41,47 
 Oleander leaves are 5 inches long. It can be sub-sessile, sessile 
alternatively spiral or irregularly scattered on the stem. Lanceolate or 
linear in shape. The surface of the leaf is shiny. Entire leaf margin or only 
the tip may have a pinnately reticulation and venelation. Bright green in 
colour and an acute apex are other features. This is shown in photograph 
3 & 3A. 
 
FLOWERS 
 In spite of its poisonous nature, the waxy yellow flowers of the 
Oleander has its own fragrance it is short lived54,16. The flowers are bell 
shaped twisted spirally with 5 lobes47. It measures  5-7cm in length and 
5cm in breath. The flowers may exhibit a pale buff cream coloured or 
coppery appearance some times. Blossoms continue to appear throught 
the year24. This is shown in photograph 4 & 4A. 
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FRUIT 
 It is globular in shape and light green in colour. It’s size is 4-5cm 
diameter and contains a single nut34,47. This is shown in photograph 5 & 
5A.  Lethal dose in children is about one to two fruits47,53,55. 
NUT 
 It is triangular or odd shaped. It has a deep groove along the edge. 
It is light brown colour. Each nut contains two seeds. It is hard like a 
stone. This is shown in photograph 6 & 6A. 8 to 10 seeds are fatal in 
adults. 
SEED 
 It is pale yellow in colour and hard like a stone, it has a covering, 
kernel and content of glycosides70,51,. 2 to 5 seeds are present in a single 
nut. This is shown is photograph 6 & 6A. 
LACTIFEROUS TISSUE24 
 It consists of thin walled greatly elongated much branched ducts 
containing milky fluid called Latex. Lactiferous ducts are two types, 
Latex vessels and Latex cells. They have numerous nuclei which lie 
embedded in this layer of protoplasm lining the cell wall which is usually 
thin and made up of cellulose. 
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LATEX4,24 
 It is a milky juice secreted by the plant, It always contain some 
waste products and it is often irritating and poisonous. It causes 
inflammation and even blister when it comes and contact with skin. This 
Latex is present in Latex cells. The secretions of this milky juice is for 
defence purpose and animals avoid such plants. This is shown in 
photograph 2. 
 
LATEX COMPOSITION 
 Latex occurs as an emulsion and consisting of variety of chemical 
substances. Among the nutritive materials sugar, starch grains, proteins 
and oils are often found. The waste products in Latex include gum, resin, 
tannin, alkaloids, rubber etc. Latex also contains some salts, enzymes and 
poisonous substances. 
 The exact function of Latex is not clear perhaps in someway it is 
associated with nutrition, healing of wounds and protection against 
parasites and animals. 
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CHEMICAL CONTENTS – ALKALOIDS24,70 
 Alkaloids are combination of organic acids and complex 
nitrogenous substances38. They may be by products of nitrogen 
metabolism in plants. They have an intensively bitter taste and are 
extremely poisonous. Majority of them are crystalline solids which are 
insoluble or sparingly soluble in water but readily soluble in alcohol. 
Alkaloids are generally but not universally formed in the roots and from 
there translocated to certains organs in the plant. The role played by the 
alkaloids in the physiology of plant cells are not known. 
 
 The most toxic glycosides56,30 in yellow Oleander are 1) Peruvoside 
2) Ruvoside 3) Thevetin – A, 4) Nerifolin, 5) Cerebrin 6) Thevetin – B, 
Peruvoside, Thevetin A & B produce effects similar to digitalis, but have 
a more rapid onset of action. 
 
 Yellow oleander does not lose its toxicity even when dried. 
Glycosides in yellow oleander undergo extensive enterohepatic cycling56. 
 Amount of glycosides per plant part is 0.07% in leaves. 0.045% in 
fruit, 4.8% seed kernel, 0.036% in sap56. 
 Thevetin cross the placenta56. 
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OLEANDER : ITS VARIOUS 
ALKALOIDS AND CHEMICAL 
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OLEANDER : ITS VARIOUS ALKALOIDS AND 
CHEMICAL STRUCTURES 
 Oleander (thevetia nerifolia) contains many glycosides which are 
mainly of cardiac action33,63. 
 This cardiac active glycosides have two major constituents60,69 
i. Aglycone or Genin or Non-sugar compound. 
ii. Sugar compound. 
AGLYCONE OR GENIN  
 This aglycone is essential for the cardiotonic and pharmacological 
activities. It has a steroid structure to which either five or six membered 
unsaturated lactone ring is attached at c17 position of steroid nucleus69. 
These aglycones are broadly divided into two sub groups. That is, 
i. Cardenolides 
ii. Bufadenolides 
Most of the aglycones of thevetia nerifolia belongs to cardenolide group. 
SUGAR COMPOUND3,60  
 These molecules are attached to aglycone. These sugars determine 
the water solubility, cell permeability and potency of glycosides. The 
duration of action of glycosides depends on the type and number of sugar 
molecules attached to it. The sugar chain consists of 1 to 5 sugars 
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occurring either as a single or repetitive units. Some of the unique sugars 
in cardiac chemistry include 
DIGITOXOSE, 6 – DEOXY SUGAR, 2 – DEOXY SUGAR, 2,6 – 
DEOXY SUGAR, DIGITALOSE, GENTIOBIOSE AND THEVETOSE. 
 Gentibiose and thevetose are more important sugars in cardiac 
glycosides of thevetia nerifolia. In the process of isolation of glycosides, 
So far monoside of digitoxigenin its 19-oxo form cannogenin and its 19-
oxy form cannogenol have been derived from the seeds and kernels of 
Thevetta nerifolia. 
 The cardenolide type of cardiac glycosides in yellow oleander plant 
are found in maximum quantities in the seed and kernels69. Root,  stem, 
bark and leaves contain lesser quantites54. The cardenolide glycosides are 
further broadly divided into two groups11,34 they are – 
i. Polarglycosides – Trioside 
ii. Secondary glycosides – Monoside 
The POLARGLYCOSIDES include thevetin-A, thevetin-B, acetyl 
thevetin-B and thevebioside. 
 The secondary glycosides include nerifolin, cereberin, peruvoside, 
ruvoside, thevernerin, thevefolin, peruvoside monoacetate and substances 
A,B,C & D. 
 The important cardiac glycosides are discussed in detail. 
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THEVETIN-A3,25 
 It has one methoxyl group and sugar. The sugar content is 
L.Thevetose plus two glucose. The chemical structure is shown in figure– 
1. 
PHARMACOLOGICAL ACTIONS70 
 Small doses of thevetin-A has stimulating effect on heart while 
large doses could depress the heart and could arrest ventricular 
contraction. Reports from many studies showed when the heart was 
stimulated by small doses of Thevetin, there was an increase in cardiac 
output and coronary blood flow. Large doses of thevetin would reduce the 
coronary blood flow. 
EFFECTS ON HUMAN HEART13 
 Administering 1 to 5 cat units of Thevetin-A by oral route will 
cause definite reduction in heart rate. The maximal effect of the drug was 
apparent in 2-3hours. Thevetin A was found to be slowly and irregularly 
absorbed by gastrointestinal tract. IV infusion produces full effect in 
about 6 minutes and the effect disappearing in about 2-3 hours. 
 The effect of thevetin-A on blood pressure is equivocal. When 
thevetin was given to patients with congestive cardiac failure, it improved 
the cardiac failure by reducing the venous pressure and by slowing 
cardiac rate. Atrial Fibrillation showed improvement with thevetin. 
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ELECTROCARDIOGRAPHIC CHANGES47,56,29,46,52 
 Electrocardiographic changes noted with thevetin are 
  BRADYCARDIA, 
  T WAVE INVERSION, 
  PROLONGED PR-INTERVAL, 
  AV DISSOCIATION, 
  VENTRICULAR TACHYCARDIA 
  VENTRICULAR FIBRILLATION. 
 Thevetin was also useful in reducing tachycardia of 
hyperthyroidism. Thevetin was used successfully in post operative thyroid 
crisis. 
THEVETIN – B3 
[ Cerebroside ] 
 It has one methoxyl group and the sugar content is L-thevetose plus 
two glucose. The chemical structure is shown in figure2. 
PHARMACOLOGICAL ACTIONS70 
 It has cardiotonic activites. It has very weak digitalis like action and 
it is one of the weakest of thevetia glycosides with the cardiotonic effects. 
The ECG changes are similar to digitalis toxicity. 
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ACETYL THEVETIN – B 
 It has one methoxyl and one acetoxyl unit. Deacetylation with 
potassium bi carbonate gives thevetin-B. The chemical structure is shown 
in figure3. 
NERIFOLIN70 
 This is the major monoside of Thevetia. It has one methoxyl unit, 
and L-Thevetose forms the sugar unit. The chemical structure is shown in 
figure4. 
 
PHARMACOLOGICAL ACTIONS30,31 
 A moderately potent cardiac glycoside having cardiotonic 
activities. 
CEREBERIN3 
(Monoacetyl Neriifolin) 
 It has one methoxy and acetoxyl groups. It is practically insoluble 
in water. The chemical structure is shown in figure5. 
PHARMACOLOGICAL ACTIONS 
 Cereberin has strychnine like activity. It has cardiotonic activity. 
 In experimental animals, cereberin produces systolic cardiac arrest, 
rise in Blood Pressure, arrhythmias and circulatory collapse. 
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PERUVOSIDE3,7 
(Oxo-Nerifolin) 
 It has one methoxyl group and L-thevetose molecule. Peruvoside 
contains an aldehyde group. Peruvoside is more prone to auto-oxidation 
especially in liquid form. The chemical structure is shown in figure6. 
 
PAHRMACOLOGICAL EFFECTS 
 Many studies have been done for the effects of peruvoside on 
cardiovascular system47. Peruvoside is effective by oral and intravenous 
routes. 
 Duration of action of the peruvoside is short. It has low serum 
protein binding nature just like OUABAIN3. Its effect on the serum in 
therapeutic and toxic doses closely resembles the other cardiac glycosides. 
 This glycoside is absorbed more from the stomach and exertion is 
mainly by bile, urine and faeces. A single dose of peruvoside disappeared 
completely in 72-96 hours. There was evidence for the presence of 
enterohepatic circulation56. The elimination of peruvoside was faster than 
digitoxin70. 
 The cardiotonic and haemodynamic effects of peruvoside on failing 
heart was done extensively by many workers3,7,49. They observed the  
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following hemodynamic effects of peruvoside in congestive cardiac 
failure. 
                     PARAMETER                                         EFFECT 
           Force of contraction        -    Powerful positive ionotrophic 
          Heart rate                        -   Decreased towards the normal heart rate
          Cardiac output                 -   Increased 
          Right atrial pressure        -   Decreased 
         Left ventricular pressure  -   Increase in sytole and mild fall in 
diastole 
        Systolic Blood pressure     -  Increased 
        Cardiac minute volume      -  Increased 
        Total peripheral resistance -  Elevated Coronary blood flow 
        Coronory blood flow          -  Augmented 
        Conductivity and excitability       -  Unaffected    
 
EFFECTS OF PERUVOSIDE ON NORMAL HUMAN HEART 
The following changes were found after intravenous peruvoside13. 
1. Increase in ejection velocity in early systole. 
2. Shortening of pre-ejection period. 
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3. Shortening of total systolic time with left ventricular ejection time 
remaining constant. 
4. Decrease in heart rate. 
5. Increase in systolic blood pressure with diastolic pressure remains 
constant. 
6. Flattening of ‘T’ waves in ECG. 
The effects of  peruvoside on congestive cardiac failure were  studied 
by  Bhatia et al 1970. They observed the following effects. 
1. Increase in cardiac index. 
2. Increase in stroke power 
3. Decrease in pulmonary arterial pressure. 
Thus peruvoside improved the myocardial function at a lowered left 
atrial pressure. 
 SPECIAL INDICATIONS for peruvoside therapy were cardiac 
Insufficiency with bradycardia, latent cardiac insufficiency, insufficiency 
of senile heart and corpulmonale chronicum and in the prophylactic 
treatment of serious conditions with stress, like surgery70. 
 Advantages of peruvoside over ouabain were its suitability for both 
oral and intravenous administration, useful in treating acute and chronic 
cardiac failure and small alterations in ECG compared to other glycosides. 
Peruvoside had low toxicity than other glycosides. 
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RUVOSIDE72 
(Thevenerin) 
 It has one methoxyl group and L-thevetose forms the sugar moiety. 
The chemical structure is shown in figure –7. 
PHARMACOLOGICAL ACTIONS70 
 The absorbtion range of ruvoside is 7 to 27% from the intestinal 
tract and completely eliminated from body in 72 to 96 hours. Ruvoside is 
quick and short acting glycoside with cumulative toxicity3. 
 At lower concentration, it produced a marked increase in the force 
of contraction accompanied by slowing of heart rate. In higher 
concentration, the heart stopped before any evidence of the positive 
ionotrophic effect could be noted. Ruvoside has a powerful emetic effect. 
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POSSIBLE MECHANISMS OF ECG 
MANIFESTATIONS IN YELLOW 
OLEANDER  POISONING 
    
POSSIBLE MECHANISMS OF ECG MANIFESTATIONS 
IN YELLOW  OLEANDER POISONING. 
 Yellow Oleander seed poisoning causes a wide variety of rhythm 
disturbances, electrocardiographic variations and abnormalities47,56. Some 
of them primarily due to cardioactive glycosides23 and some are 
secondary to other factors like electrolyte imbalance, hypoxia, acidosis 
etc26. 
 Cardiac glycosides in yellow oleander will alter the cardiac muscle 
physiological properties69 such as automaticity, rhythmicity, conductivity 
and contractility. 
AUTOMATICITY AND RHYTHMICITY32,35,45 
 Automaticity and rhythmicity are the primary function of Sino 
Atrial Node  which has the most automatic cells and hence it is the natural 
pacemaker. Clinically arrhythmias may result from alteration of 
automaticity of sinus node or from an abnormal impulse formation from 
ectopic automatic tissue. 
 In yellow oleander poisoning the abnormality in automaticity and 
rhythmicity are seen as follows. 
A. SLOWING OF AUTOMATICITY – Sinus bradycardia 
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B.  ALTERATION OF RHYTHMICITY – Escape rhythm formation 
presenting as. 
1. Sinus bradycardia with juctional escape rhythm. 
2. AV dissociation 
3. Escape rhythm without sinus activity. 
With the onset of escape rhthym there is a shift in the pacemaker activity 
and the subsidary pacemaker which remain latent under normal condition 
because of faster rate of impulse formation by SA node, becomes active. 
In oleander poisoning AV node takes the brunt and becomes the 
secondary pacemaker in many instances, which may present as 
1. AV nodal tachycardia 
2.  Tachy-Brady syndrome. 
Abnormalities of depolarization and repolarization in yellow oleander 
poisoning are represented by ST depression and T wave inversion. 
 Many factors influence the repolarization process.  Some of them in 
oleander posioning are myocarditis and electrolyte imbalance. 
 In yellow oleander poisoning most of the primary T wave changes 
seen are suggesting an abnormality of the repolarization due to toxic 
effects, producing an element of myocarditis and furthur influenced by 
electrolyte imbalance mostly related to potassium changes56. 
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ANATOMICAL BASIS OF ECG CHANGES IN  
YELLOW OLEANDER POISONING 
 From various ECG changes it is possible to isolate certain areas in 
conducting system which are affected in yellow oleander poisoning. 
 
SINO ATRIAL NODE 
 SA node is commonly involved64 and has been shown in the form 
of  DEPRESSION  and also as a part of SICK SINUS SYNDROME. The 
brady type of sick sinus syndrome is most common type. 
ATRIO VENTRICULAR JUNCTION 
 It is also commonly affected by toxic principles of oleander and this 
leads to variety of rhthym disturbances69 like A.V.nodal rhythm, AV 
nodal tachycardia etc. 
BUNDLE OF HIS 
 Right bundle branch is occasionally involved. 
 Left bundle branch is never involved. 
 Intraventricular portion is rarely involved. 
MYOCARDIUM 
 Myocardium is involved in different ways eg: myocarditis made out 
by various non specific changes producing ST and T wave changes. 
 
23 
    
 ECG abnormalities in  yellow oleander  poisoning is multifactorial. 
So it can be discussed in relation to various factors. 
1. The role of cardioactive glycosides. 
2. Contributory Autonomic system alterations in arrhythmogenesis. 
3. Electrolyte imbalance    
4. Myocarditis 
5. Acidosis  
6.  Hypoxia     
7. Hypotension and shock 
8. Vascular factors 
9. Combination of factors. 
ROLE OF CARDIO-ACTIVE GLYCOSIDES. 
 Thevetia nerifolia contains cardioactive glycosides. Yellow 
oleander glycosides closely resemble other cardiac glycosides in structure 
as well as toxic and pharmacological effects. In decreasing order of 
potency the glycosides of yellow oleander are Peruvoside, Ruvoside, 
Thevetin-A, Neriifolin, Cereberein and Thevetin – B56. They are all have 
an aglycone (digitonigenin or its derivatives ) combined with a sugar and 
act by inhibiting  NA+K+-ATP ase31,67. 
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SODIUM POTASSIUM –ATP ASE 
 In 1957, Jens Skou discovered an enzyme that hydrolysis ATP only 
if Na+ and k+ are present in addition to Mg2+ which is required by all 
ATP ases and names as Na+k+-ATP ase. 
 Cardiotonic steroids inhibit the pump and the ATP ase, only when 
they are located outside the cell. The Na+K+ATP ase is an integral 
membrane protein with two subunits with the molecular weight2 of 
~50,000 and ~1,10,000. 
 The activity of this Na+K+ATP ase is an essential cell function. 
Every animal cell maintains a low concentration of Na+ and a high 
concentration of k+ than is found in its surrounding medium. This is done 
by Na+k+-ATP ase which couples breakdown of ATP to simultaneous 
movement of both Na+ and k+ against their concentration gradient. For 
each molecule of ATP converted to ADP and pi, this transporter moves 
2k+ions  inward and 3 Na+ions outward across the plasma membrane and 
this process is electrogenic. 
INHIBITION OF NA+K+ATP ASE6,17,25,31 
 All glycosides in yellow oleander are potent inhibitors of active 
transport of Na+ and k+ across cell membrane by binding to a specific site 
on the extracytoplasmic face of α  subunit  of Na+k+ATP ase. 
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 The binding of cardiac glycosides to Na+k+-ATP ase and inhibition 
of cellular Na+ pump is reversible and entropically driven. These 
glycosides bind preferentially to the enzyme following phosphorylation at 
β-asparate on the cytoplasmic face of the ∝  subunit and stabilize this 
conformation known as E2P. 
 
 The positive inotropic effects of the glycosides are due to an 
increase in the availability of cytosolic Ca++ during systole to interact 
with contractile proteins to increase the velocity and the extent of 
sacromere shortening. This increase in  intracellular Ca++ is one of 
consequences of cardiac glycoside induced decreased cycling of the 
sarcolemmal Na+k+ATP ase. 
 
 Hence it can be definitely concluded that some of the ECG changes 
are due to the presence of cardioactive glycosides and principle in yellow 
oleander, which are toxic to conductive system. 
 
CONTRIBUTARY AUTONOMIC NERVOUS SYSTEM 
 Though the role of autonomic nervous system is not clear, it 
appears that it contributes to the ECG abnormalities. 
 Increased vagal tone is responsible for the following ECG changes 
like sinus bradycardia, sinus arrhythmias, SA block, premature beat, AV 
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block, junctional rhythm, junctional escape, AV dissociation, ventricular 
escape and cardiac arrest. 
 
 Yellow oleander  seeds contain many cardioactive glycosides and 
some of them are similar to digitalis and this can be explained on the basis 
of similarities in basic chemical structure and sugar linkage. Many of  the 
above rhthym disturbances are therefore probably induced by autonomic 
imbalance mediated in many cases. Hence Atropine  can be used as a 
diagnostic agent to unmask autonomic imbalance in arrhythmogenesis 
induced by toxic principles in yellow oleander seeds. 
 
ROLE OF ELECTROLYTE IMBALANCE 
 Electrolyte imbalance are commonly seen in yellow oleander 
poisoning. The biochemical features include hyponatremia, 
hyperkalaemia and hypochloremic acidosis. Hyperkalaemia is commonly 
associated with yellow oleander poisoning. The potassium abnormalities 
are also contributing to arrhythmias in yellow oleander poisoning. 
 
ROLE OF MYCARDITIS52 
 Yellow oleander poisoning may produce a picture of toxic 
myocarditis and this can explain some of the ECG changes. 
27 
    
 Although there is no single specific ECG abnormality diagnostic of 
myocarditis, most common ECG finding is diffuse ‘T’ wave change in the 
form of T wave inversion in many leads. The other changes are varying 
degrees of AV Block, Bundle branch block, non-specific intraventricular 
conduction disorders, ectopics etc. The uncommon features are non-
specific ST-T changes in the form of sagging or depression, prolonged 
QT, notched (or) broad P and ectopic tacharrhythmias. 
 Hence an element of myocarditis is present in yellow oleander 
poisoning and steriods are used in the treatment. 
ROLE OF VASCULAR FACTORS11 
 Myocardial ischaemia secondary to involvement of the coronary 
artery may be an additional operative factor in the production of some of 
the ECG changes.  
 ST depression is classically seen in inferior and anterior leads. 
Although the glycosides and electrolytes can produce similar changes, 
coronary vasospasm was thought in experimental studies. Toxic doses of 
thevetin and subsidiary glycosides in the nuts of thevetin nerifolia can 
produce vasoconstriction64. 
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AIM OF THE STUDY 
 
    
AIM OF THE STUDY 
1. TO STUDY THE ELECTRO CARDIOGRAPHIC CHANGES IN 
YELLOW OLEANDER SEED POISONING. 
2. TO STUDY THE COMMON TYPE OF ARRYTHMIAS 
OBSERVED. 
3. TO STUDY THE AGE AND SEX INCIDENCE IN OLEANDER 
POISONING. 
4. TO CORRELATE THE NUMBER OF SEEDS WITH THE 
SEVERITY OF ECG CHANGES. 
5. TO CORRELATE THE FORM OF CONSUMPTION OF SEEDS 
WITH THE SEVERITY OF ECG CHANGES. 
6. TO STUDY THE BIOCHEMICAL PROFILE IN OLEANDER 
SEED POISONING. 
7. TO STUDY THE NECESSITY OF STOMACH WASH. 
8. TO STUDY THE COMMON SYMPTOMS IN OLEANDER 
SEED POISONING. 
9. TO STUDY THE TIME LAPSE OF 
ELECTROCARDIOGRAPHIC CHANGES BECOMING NORMAL. 
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MATERIALS AND 
METHODS OF STUDY 
    
MATERIALS AND METHODS  
OF STUDY 
DESIGN 
 This is a single centre non-randomised prospective study is 
determining the  clinical profile and electrocardiographic changes among 
51 patients with yellow oleander seed poisoning. 
STUDY PERIOD 
 Patients in and around Thanjavur District admitted for yellow 
oleander seed poisoning in Thanjavur Medical College Hospital during 
the period of one year between July 2006 to June  2007 were taken up for 
this study. 
STUDY CENTRE 
 This study was carried out at Department of Medicine, Thanjavur 
Medical College Hospital, Thanjavur, South India. 
 All cases were examined in detail in the wards and findings were 
recorded in the proforma annexed herein. All cases were followed till 
their discharge or death. Post mortem was done in the expired patient and 
the heart was studied in detail. 
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HISTORY DETAILS 
 All cases were examined for the age, sex, socioeconomic status and 
literacy. 
 All details about poisoning like colour of the oleander, number of 
seeds, form of consumption like paste, grounded or chewed, with or 
without leaves, with or without food or empty stomach were enquired. 
 Time of poisoning, time of admission to Hospital, episodes of 
vomiting, symptoms like chest pain, palpitation, giddiness, syncope, etc. 
details about first aid were enquired. 
CLINICAL EXAMINATION 
 All cases were examined clinically for pulse rate, Blood pressure, 
State of Higher functions, cardio vascular system, respiratory system, 
central Nervous system and Gastro intestinal system involvement. 
LABORATORY INVESTIGATIONS 
 URINARY EXAMINATIONS 
  Urine Albumin 
  Urine Sugar 
  Urine Deposits 
 BLOOD EXAMINATION 
  Blood Sugar 
  Blood Urea 
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  Serum Creatinine 
  Serum Electrolytes 
ELECTRO CARDIOGRAM 
 ECG was taken in all cases immediately  after admission. Routine 
conventional limb leads, chest leads and long strip were recorded. Serial 
ECG were recorded at 12 hours interval for first 3 days of admission and 
thereafter ECGs were taken every 24hrs till discharge. 
 ECGs were interpreted fully in the following way as rate, rhythm, 
axis, ‘P’ waves, PR interval, QRS, T, ST.Q.Tc interval and ‘U’ Wave. 
 Positive observations in the ECG are shown here. The normal 
values of all ECGs are depicted in the ECG master chart. 
AUTOPSY 
 Postmortem was done in death. Macroscopic appearance of various 
organs and microscopic appearance of heart were studied in detail. 
TREATMENT 
 Patients were treated with stomach wash, Few patients were treated 
with activated charcoal stomach wash, followed by Ryle’s tube 
aspiration, IV fluids and steroids, with continuous monitoring of few 
cases. Atropine  and orciprenaline were given if heart rate was below 60 
per minute. Due to lack of pacing facilities temporary or permanent  
pacemaker was not  tried. 
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RESULTS, OBSERVATIONS 
AND DISCUSSION 
    
RESULTS, OBSERVATIONS  
AND DISCUSSION 
AGE INCIDENCE 
 Out of the total of 51 cases, the number of patients between the age 
group of below 20 were 20(41.17%) and between the age group of 21-30 
were 19(37.25%) and between the age group of 31-40 were 11(21.56%) 
and in the age group of above 70, 1 patient(1.96%). 
 Incidence of poisoning is more in age group below 20 years. It is 
shown in table 1 given below. 
Tab 1. Showing Age incidence 
AGE GROUP IN 
YEARS 
NUMBER OF 
PATIENTS 
PERCENTAGE 
20 and below 
21 – 30 
31 – 40 
Above 70 
20 
19 
11 
1 
41.17% 
37.25% 
21.56% 
1.96% 
SEX INCIDENCE 
 Out of the total of 51 cases, 19 cases were males and 32 were 
female. 
Male : Female ratio was 1:1.6. 
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 Percentage of males in this study was 37.2%. In men the common 
age group was 21-30 years and the number of cases in this age group was 
9(47.36%). 
 Number of cases in the age group below 20 years were 6(31.57%). 
The number of cases in the age group of 31-40 were 3(15.78%). One was 
in the age group of above 70 (5.26%). 
 Incidence appears more in females than males and the percentage 
of females in this study was 62.7%. 
In females the common age group of poisoning was below  20 years of 
age and the number of cases in this age group were 14(43.75%). Number 
of female patients in the age group of 21-30 years were 10(31.25%) and 
between 31-40 years were 8(25%). It is shown in table 2 given below. 
Tab 2. showing sex incidence 
Male Female Age Group in  
Years Number of 
Patients 
% 
Number of 
Patients 
% 
20 and below 
21 – 30 
31 – 40 
Above 70 
6 
9 
3 
1 
31.57%
47.36%
15.78%
5.26% 
14 
10 
8 
 
43.75%
31.25%
25% 
 
Total 19 37.2% 32 62.7% 
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Showing Sex and ECG 
abnormalities
63.15%
46.87%
Male
Female
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
    
High incidence in female sex was below 20 yrs and in the male, 20 – 30 
yrs of age. 
 
MORTALITY AND AGE 
 Overall mortality in this study was 1(1.96%). Patient was a female 
in the age group of 20 – 30. 
Table 3. showing age in relation to mortality 
AGE GROUP  
IN YEARS 
NUMBER OF 
PATIENTS 
PERCENTAGE 
20 - 30 1 1.96% 
Total 1 1.96% 
 
High mortality could be due to delay in admission and 
consumption of more number of seeds. The death was due to ventricular 
fibrillation.  
MORTALITY AND SEX 
 The percentage of mortality in male was NIL and in female was 
1.96% this is shown in table 4 given below. 
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Tab 4. Showing sex in relation to mortality 
Male Female Age Group in  
Years Number of 
Patients 
% 
Number of 
Patients 
% 
1(1.96%) Nil - 1 1.96%
FORMS OF CONSUMPTION 
 The seeds were taken in many forms but the most common form of 
consumption was grounded form. 
 Number of patients consumed in grounded form were 35 (68.62%) 
and in paste form were 7(13%) and in bitten and chewed form were 
3(5.88%). Only 1(1.96%) patient had consumed leaves along with seeds. 
It is shown in table 5. 
Tab 5. Showing the forms of poison consumed. 
Total Number  
Of Patients 
Form of 
Consumption 
Number of 
Patients 
Percentage 
Grounded 35 68.62% 
Paste 7 13% 
Chewed 3 5.88% 
Seeds with 
Leaves 
1 1.96% 
51 
Whole seed 6 11.76% 
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Showing the forms of poison 
consumed
68.62%
13%
5.88%
1.96%
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 In grounded and paste form the alkaloid availability is more and 
hence the electrocardiographic manifestations and mortality were high in 
this form. 
 Most of the poisons consumed were seeds, poisoning by leaves 
were less. Even in those cases they did not exhibit serious manifestations. 
 In the patient who died, the form of consumption was grounded 
form. 
 
TIME INTERVAL BETWEEN CONSUMPTION 
OF POISON AND ADMISSION 
 Number of patients admitted within 6 hours of poisoning were 
38(74.5%) between 6 – 12 hours of poisoning were 10(19.6%) and 
beyond 12 hour of poisoning were 3(5.88%). This is shown in table 6 
given below. 
 
Tab 6. Showing time of admission after poisoning 
Total Number 
of Patients 
Time Interval between 
poisoning and admission 
Number of 
patients 
Percentage 
Less than 6 hours 38 74.5% 
6 – 12 hours 10 19.6% 53 
More than 12 hours 3 5.88% 
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 When the delay was more than 10 – 12 hours the chance of 
mortality was high. 
 
NUMBER OF SEEDS CONSUMED 
 Number of patients consumed 1 seed were 3(5.88%), 2 seeds were 
2(3.92%), 3 seeds were 9(17.64%), 4 seeds were 14(27.45%), 5 seeds 
were 15(29.41%), 6 seeds were 2(3.92%), 11 seeds were 1(1.96%). This 
is shown in table 7 given below. 
Tab 7: Showing number of seeds consumed 
Number  of Seeds Consumed Number of Patients 
Percentage 
 
1 3 5.88% 
2 2 3.92% 
3 9 17.64% 
4 14 27.45% 
5 15 29.41% 
6 2 3.92% 
7 1 1.96% 
8 2 3.92% 
9 - - 
10 2 3.92% 
11 1 1.96% 
Total Number of Patients 51  
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Mortality appears high when patient consumed more than 3 seeds 
and also the form of consumption being grounded or paste. 
 There seems to be a definite abnormality in ECG, even though 
there is no mortality, if patient had taken even one seed. 
 The ECG  changes and mortality had more relationship with the 
grounded, chewed or paste form of seeds rather than the number of seeds. 
 
AUTOPSY 
 In one case we were able to do a complete postmortem and harvest 
heart fully. Tissues were taken at various places of conducting system and 
detailed histopathological examination was done. 
 Macroscopic appearance of various organs especially heart were 
studied. Stomach and duodenum were congested, stomach had showed 
fragments of seeds. There was engorgement of veins of the heart. 
INCIDENCE OF ECG ABNORMALITIES 
 Out of the total of 51 patients, 27 patients had electrocardiographic 
abnormalities and 24 patients had normal ECGs. This is shown in table 8 
given below.  
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Tab 8: showing incidence of ECG abnormalities 
Total 
Number of cases with  
ECG abnormalities 
% 
Number of cases with  
Normal ECG  
% 
51 27 52.94% 24 47.05%
 Out of 24 normal cases, 2(3.92%) patient had consumed only one 
seed. 2(3.92%) patients had consumed 2 seeds, 8(15.68%) patients had 
consumed 3 seeds, 8(15.68%) patients had consumed 4 seeds and 
2(3.92%) patients had taken 5 seeds and the 1(1.96%) patient had taken 8 
seeds, 1(1.96%) patient had taken 10 seeds. 
 In general ECG abnormalities were noted when patients consumed 
more than 3 seeds. 
 Approximately 52.94% of cases of oleander seed poisoning had 
ECG abnormalities. According to another study done by BoseTK, Basu 
RK in India8, ECG abnormalities occurred in 46% of cases. 
AGE AND ECG ABNORMAILITIES 
 Out of the total of 20 patients admitted in the age group below 20 
years (60%) patients had showed ECG abnormalities. 
 Out of 19 patients in the age group 21 – 30 years 10(52.63%) 
patients had developed ECG abnormalities. 
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 Out of 11 patients in the age group of 31 – 40 years 6(54.54%) 
cases had ECG abnormalities. This is shown in table 9 given below. 
Tab 9: Showing age and ECG abnormalities. 
Age Group 
In years 
No. of Patients 
No. of Patients 
with ECG 
changes 
% 
20 and below 
21 – 30 
31 – 40 
20 
19 
11 
12 
10 
6 
60% 
52.63% 
54.54% 
 In our study ECG abnormalities were seen equally in all age 
groups. 
SEX AND ECG ABNORMALITIES 
 Out of total 19 males, 12(63.15%) males had developed ECG 
abnormalities and out of 32 females, 15(46.87%) had ECG abnormalities. 
This is shown in table 10 given below. 
 
Tab 10: Showing sex and ECG abnormalities. 
Sex 
Total No. of 
Patients 
Patients with  
ECG changes 
Percentage 
Male 
Female 
19 
32 
12 
15 
63.15% 
46.87% 
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There is a marginal increase in ECG abnormalities noted in males 
by 13.15%. 
TIME OF APPEARANCE OF ECG ABNORMALITIES 
 Out of the total of 51 cases 6(83.33%) cases were admitted within 
2 hours of poisoning and in that five cases 5(80%) had ECG 
abnormalities. In one 1(1.96%) patient ECG abnormalities appeared as 
late as 24 hours after poisoning. In this study ECG abnormalities were 
noted as early as within 2 hours and as late as 24 hours of poisoning. 
NUMBER OF SEEDS AND ECG ABNORMALITIES 
 In this study out of 51 patients 3(5.88%) patients consumed only 
one seed. In that 3 cases 1 (33.33%) patient had sinus bradycardia and 
2(66.66%) patients had no arrhytmias. ECG abnormalities appear even in 
one seed. 
 2(3.93%) patients had consumed 2 seeds and both had normal 
ECGS . 9(17.64%) patients had taken 3 seeds. In that 8(8.88%) of them 
had no ECG changes. Only one patient had sinus bradycardia. No other 
changes were noted. 
 14(27.45%) cases had consumed 4 seeds. In that 14 cases, 
6(42.85%) patients had developed arrhythmias in the form of sinus 
bradycardia, sinoartrial block, first degree atrioventricular block, T wave  
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inversion, ST depression and ventricular tachycardia. 8(57.14%) patients 
had normal ECG. 
 15(29.41%) patients consumed 5 seeds and 13(86.66%) of them 
had developed arrhythmias in the form of sinus bradycardia, Sinus 
tachycardia, SA Block, Ischaemic changes and 2(13.33%) patients had 
normal ECGs. 
 2(3.92%) patients had taken 6 seeds and both(100%) of them had 
showed arrhythmias in the form of sinus bradycardia block. 
 1(1.96%) patient admitted with consumption of 7 seeds had 
arrhythmias in the form of sinus bradycardia and sinus tachycardia with 
second degree AV block. 
 2(3.93%) cases had taken 8 seeds and arrhythmias were seen in 
1(50%) patient one had normal ECG. 
 2(3.92%) patients had admitted with history of consumption of 10 
seeds. 1 case(50%) had normal ECG and the other had type 1 AV Block 
and sinus bradycardia. 
 1 patient had taken 11 seeds and in that patient serial ECGs showed 
sinus bradycardia, first degree AV Block. 
 This study shows ECG abnormalities are seen even with one seed. 
If they consumed more than 5 seeds there is more possibilities for 
occurence of arrhythmias. This is shown in table 11.
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Table 11. Showing number of seeds taken and ECG Abnormalities 
 
Patients with ECG Abnormalities 
Normal ECGs No of seeds 
taken 
Total 
no of 
cases 
Abnormal 
ECGs % 
Sinus 
Bradycardia
Sinus 
Tachycardia ST T 
SA 
Block 
10AV 
Block 
20AV 
Block VT No. of 
Cases % 
1 3 1 33.33 1 - - - - - - - 2 66.66 
2 2 - - - - - - - - - - 2 100 
3 9 1 17.64 1 - - - - - - - 8 88.8 
4 14 6 42.85 2 - 1 1 1 1 - 1 8 57.14 
5 15 13 86.66 7 2 2 1 1 - - - 2 13.33 
6 2 2 100 2 - - - - - - - - - 
7 1 1 - 1 1 - - - - 1 - - - 
8 2 1 50 1 - - - - - - - 1 50 
10 2 1 50 - - - - - 1 - - 1 50 
11 1 1 100 1 - - - - 1 - - - - 
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VARIOUS FORM OF ECG ABNORMALITES 
 Out of 27 patients with ECG abnormalities 16(59.25%) patients 
had sinus bradycardia, 3(11.11%) patients showed sinus tachycardia. 
 2(7.4%) patients showed T wave inversion and 3(11.11%) patients 
showed ST segment depression. SA Block was noticed in 2(7.4%) 
patients. 
 3(11.11%) patients had showed first degree atrioventricular block, 
1(3.7%) patient had second degree atrioventricular block  
 One patients (3.7%) had ventricular tachycardia. 
ECG ABNORMALITY AND MORTALITY 
 In this study 1 patient expired. ECG showed ventricular 
Tachycardia. 
 This is shown in Table 12. 
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Table 12. Showing various forms of Arrhythmias 
 
 
 
ECG 
Abnormalities 
Sinus 
Bradycardia 
Sinus 
Tachycardia
SA 
Block 
ST 
Depression 
‘T’ 
Inversion
10 AV 
Block 
20 
AV 
Block
Ventricular 
Tachycardia
Total 
Abnormal 
ECGs 
Number of 
Patients 
16 3 2 3 2 3 1 1 27 
Percentage % 59.25% 11.11% 7.4% 11.11% 7.4% 11.11% 3.7% 3.7% 100% 
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TIME OF DISAPPEARANCE OF ECG ABNORMALITY 
 Out of 27 patients with ECG abnormalities 10(37.03%) patients 
ECG reverted to normal within 24hrs after admission. 8(29.6%) patients 
ECG became normal between 24 – 48 hours after admission. 7(25.92%) 
patients ECG became normal between 48 – 72 hours and 1 (3.7%) 
patients ECG became normal between 72 – 96 hours after admission and 
1 (3.7%) patients after 96 hours. This is shown in table 13 given below. 
 The ECG abnormality persisted upto 5 days so in all cases ECG to 
be monitored for 5 days compulsorily.  
Tab 13. Showing time of disappearance of ECG abnormalities 
Time of  
disappearance of ECG 
abnormalities in hours
No. of 
Patients 
% 
No. of 
deaths 
Less than 24 hours 10 37.03% - 
24 – 48 8 29.6% - 
48 – 72  7 25.92% 1 
72 – 96 1 3.7% - 
96 - 120 1 3.7% - 
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 Yellow Oleander poisoning is common under the age group 
of below 30 years. Female patients are more in number than male 
patients. 
 The cardiac arrythmias in yellow oleander poisoning are associated 
with high serum cardiac glycosides level and electrolyte disturbances like 
hyperkalemia56. 
 The mean cardiac glycoside level of 2.88 n mol/ litre present with 
AV Block. The mean cardiac glycoside level of 3.10 n mol / litre present 
with both AV Block and sinus node dysfunction56. 
 Patients with moderate toxicity present with Electrocardiographic 
changes of  prolonged PR interval later proceding to AV dissociation 
Patients with severe toxicity dies due to ventricular fibrillation56.  
 Patients usually have conduction defects affecting sinus node and 
AV node and a few cases present with atrial and ventricular 
tachyarrythmias or ventricular ectopic beats that are typical of digoxin 
poisoning26. 
 Studies conducted by Bose TK & Basu RK published in 1990 in 
Calcutta showed that 82% percentage of patients were females, while it 
was 62% percentage in our studies. 
 The number of seeds varied from Half to fifteen in their study, 
while it was one  to Eleven seeds in our study. 
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 Nearly seventy five percentage of patients reached hospital within 
6 – 8 hours in both studies. 
 Patients with symptoms of vomiting in our study was 26.31% 
which was 30.66% in that study. 
 Palpitation symptoms were present in 11.76% of our patients, 
which was 12% in that study. 
 One patient presented with diarrhea and  another patient with 
syncope in our study. 5(9.8%) patients had hyperkalemia in our study. 
Patients admitted within 6 hours of poisoning, patients who were given 
early stomach wash, patients who had early vomiting within few hours 
after consumption, patients who had taken seeds after food intake had 
good prognosis and outcome. 
 Patients were discharged with 100% normal ECG in our studies. 
Multiple dose activated charcoal binds cardiac glycosides in the gut 
lumen and promote their elimination. They reduced the fatalites  by about 
70% in studies conducted in Srilanka on yellow oleander seed 
poisoning19,58. 
 Antidigoxin fab fragments37,18 have been found to be effective in 
reducing the severe cardiac arrythmias and mortality in patients with 
yellow oleander seed poisoning. The results have been published in 
journals and studies conducted in Srilanka42,20,15,14,27,62,59,2. 
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CONCLUSION 
1. Common age groups of  Oleander seed poisoning  in our study was 
less than 30 years. 
2. Study revealed higher incidence of poisoning in females. 
3. Mortality was related to delay in admission, stomach wash,  
grounded, chewed or paste  from of  consumption, electrolyte 
imbalance like hyperkalemia and cardiac arrythmias. 
4. Study revealed ECG abnormalities in about 53% of patients. 
5.  There was increased mortality if the seed consumption was more 
than three in number. 
6. The ECG abnormalities in males exceeded the females by nearly 
20%. 
7. ECG abnormalities  appeared as early as 2 hrs and as late as 24 
hours of poisoning. 
8. ECG abnormalities were equal in all age groups studied. 
9. The ECG abnormalities  had no independent relationship with the 
number of seeds of consumption. 
10. Sinus bradycardia was the commonet arrythmia observed in our 
study. 
11. Ventricular tachycardia and fibrillation were also observed. 
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12. Patients given early stomach wash with or without activated 
charcoal had good prognosis and out come. 
13. ECG abnormalities lasted for 5 days which emphasizes ECG 
monitoring or sequential ECGs  for minimum of five days. 
14. Patients on discharge had 100% normal ECGS. 
15. Bundle Branch Block was not noted in this study. 
16. Next to Sinus bradycardia, Io AV Block and ST-T changes were 
noted in this study. 
17. Vomiting and palpitation were the common symptoms of 
presentation. 
18. Symptoms of syncope and diarrhea were also reported. 
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PROFORMA 
1. NAME 
2. AGE  
3. SEX 
4. OCCUPATION 
5. LITERACY 
6. I.P.NUMBER 
7. DATE OF ADMISSION 
8. DATE OF DISCHARGE 
9. DATE AND TIME OF POISONING 
10. DATE AND TIME OF ADMISSION 
11. TIME INTERVAL BETWEEN CONSUMPTION OF POISON AND 
ADMISSION 
12. DETAILS OF POISONING 
a. COLOUR 
b. NUMBER OF SEEDS 
c. WITH LEAVES 
d. WITHOUT LEAVES 
e. QUANTITY 
f. FORM GROUNDED 
g. CHEWED 
h. PASTE 
i. WITH FOOD 
j. EMPTY STOMACH 
13. BEFORE ADMISSION 
a. VOMITING         YES / NO 
b. TIME INTERVAL BETWEEN CONSUMPTION & VOMITING YES / NO 
    
c. FIRST AID 
14. AFTER ADMISSION 
a. GASTROINTESTINAL SYMPTIONS 
i. BURNING SENSATION OF MOUTH YES / NO 
ii. TINGLING SENSATION OF TONGUE YES / NO 
iii. DRYNESS OF THROAT   YES / NO 
iv. VOMITING      YES / NO 
v. DIARRHOEA 
b. CARDIOVASCULAR SYMPTOMS 
i. SYNCOPE      YES / NO 
ii. PALPITATION     YES / NO 
iii. DYSPNOEA     YES / NO 
c. CENTRAL NERVOUS SYSTEM SYMPTIONS 
i. BLURRING OF VISION   YES / NO 
ii. HEADACHE     YES / NO 
iii. ALTERED SENSORIUM   YES / NO 
iv. TETANIC CONVULSIONS   YES / NO 
v. COMA      YES / NO 
15. CLINICAL EXAMINATION 
a. VITAL SIGNS 
b. TEMPERATURE 
c. PULSE 
d. BLOOD PRESSURE 
e. RESPIRATORY RATE 
f. PUPILS 
g. CARDIOVASCULAR SYSTEM 
h. RESPIRATORY SYSTEM 
i. ABDOMEN 
    
j. CENTRAL NERVOUS SYSTEM 
16. INVESTIGATIONS 
a. URINE 
i. ALBUMIN 
ii. SUGAR 
iii. DEPOSITS 
b. BLOOD 
i. UREA 
ii. SUGAR 
iii. SERUM CREATININE 
iv. SERUM ELECTROLYTES’ 
c. ELECTROCARDIOGRAM 
17. AUTOPSY 
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Electrocardiogram 
Symptoms S. 
No Name 
Age 
/Sex IP.No 
Date & 
Time of 
Admission 
Date & Time 
Poisoning 
Time 
Inter 
val in 
Hours 
S.W 
with 
Char 
coal 
No. 
Seeds 
/Form V Pa O 
I II III IV V VI VII VIII 
B 
S 
Mgs% 
B 
U 
Mgs% 
S 
Cr 
Mgs% 
S 
Na 
Mg/dl 
S 
K 
Mg/dl 
1. Eswari 24/F 884194 3/7/06 6.40pm 
3/7/06 
2.10pm 4.30 - 5/P    SB SB SB SB SB SB SB N 92 20 0.8 135 4.2 
2. Seetha 25/F 885513 15/7/06 6.25am 
14/7/06 
10.15pm 8.10 - 5/G - - - STv STv N N N N - - 108 24 0.8 136 4.0 
3. Anitha 29/F 887013 8/8/06 6.00pm 
8/8/06 
2.45pm 3.15 + 4/G - - - N N N N N - - - 96 30 1.0 135 4.5 
4. Annam 38/F 888003 18/8/06 1.10pm 
18/8/06 
11.10am 2.00 - 4/G - - - N N N N - - - - 112 26 1.0 132 4.5 
5. Rama mirtham 25/F 891016 
17/9/06 
6.00am 
16/8/06 
10.00pm 8.00 - 4/G - - - STv STv STv N N N N - 110 32 1.0 130 4.2 
6. Lalitha 21/F 891218 20/9/06 11.30am 
20/9/06 
8.45am 2.45 + 4/G - - - N N N N N - - - 130 30 0.8 132 4.0 
7. Jeyapaul 24/M 891312 21/9/06 6.15pm 
21/9/06 
10.45am 7.30 - 4G - - - SB SB SB SB N N N - 129 36 1.0 130 3.8 
8. Rani 22/F 892034 1/10/06 9.40am 
1/10/06 
8.40am 1.00 - 4G - - - N N N N - - - - 115 24 0.8 132 4.0 
9. Vijayakumar 25/M 892939 9/10/06 8.30pm 
9/10/06 
10.30am 10.00 - 8G - - - 
SB 
I0AVB 
SB 
I0AVB 
SB 
I0AVB SB N N N N 118 26 1.0 130 42 
10 Ilayaraja 21/M 894539 25/10/06 12.30am 
24/10/06 
10.00pm 2.30 + 3P - - - N N N N - - - - 100 30 1.0 136 4.0 
11 Kolajinathan 28/M 895942 8/11/06 10.10pm 
8/11/06 
5.25pm 4.45 - 5G + - - N N N N N - - - 122 28 1.0 132 4.2 
12. Raji 26/F 896239 11/11/06 12.30pm 
11/11/06 
7.20am 5.10 + 4P - - - N N N N N - - - 108 24 1.0 130 3.5 
13 Murugesan 32/M 896450 13/11/06 8.25pm 
13/11/06 
3.25pm 4.50 - 11G - - - 
SB 
I0AVB 
SB 
I0AVB N N N - - - 112 28 1.2 130 5.5 
14 Kokila 15/F 918451 3/12/06 11.30am 
13/12/06 
5.00am 6.30 - 4P - + - SB SB SB SB N N N - 126 30 1.0 128 4.5 
15 Joyce mary 16/F 918469 3/12/06 4.10pm 
3/12/06 
7.10pm 3.00 - 8/G + - - N N N N N N - - 130 20 1.0 130 4.4 
16 Malarvizhi 19/F 918654 4/12/06 5.05pm 
4/12/06 
12.15pm 4.50 - 3/W - - - N N N N N N - - 132 26 1.0 128 4.0 
17 Kalaiyarasu 17/M 919093 9/12/06 3.00pm 
9/12/06 
6.40am 8.30 + 5/G - - - SB SB SB SB N N - - 106 28 1.0 130 4.0 
18 Malika 15/F 919506 13/12/06 7.50pm 
13/12/06 
2.50pm 5.00 - 5/G - - - SB SB N N N N - - 112 30 1.0 132 5.2 
19 Savithri 35/F 920632 23/12/06 8.20pm 
23/12/06 
5.00pm 3.20 - 4/P - - + SB SB SB SB N N - - 118 28 0.8 128 4.5 
20 Sathiyaraj 20/M 921120 28/12/06 2.40am 
27/12/06 
10.00pm 4.40 - 5/P + - - ST ST ST ST N N N N 108 30 0.8 130 4.2 
21 Ramesh 26/M 921246 29/12/06 8.50pm 
29/12/06 
3.15pm 5.35 + 3/G - - - N N N N N - - - 96 20 1.0 128 4.0 
22 Parvathi 33/F 921887 05/01/07 1.40am 
4/1/07 
10.00pm 3.40 - 3G + - - N N N N N - - - 100 20 1.0 130 4.0 
23 Malarvizhi 15/F 921939 6/1/07 12.15pm 
6/1/07 
6.15am 6.00 - 5/W + - - N N N N - - - - 98 26 1.0 132 4.0 
24 Subhiah 17/M 922800 15/01/07 3.50pm 
15/01/07 
10.00am 5.50 - 2/G - - - N N N N - - - - 102 20 0.8 130 4.2 
25 Ranjitha 14/F 922945 23/1/07 9.10pm 
23/1/07 
4.00pm 5.10 - 4/G + - - N N N N - - - - 108 24 1.0 130 4.5 
    
 
 
 
26 Chitra 29/F 923328 27/1/07 8.15pm 
27/1/07 
4.15pm 3.30 + 4/G - - - N N N N - - - - 132 30 1.0 128 4.0 
27 Vanakamudi 35/M 923419 28/1/07 10.30am 
27/1/07 
10.00pm 12.30 - 7/G + - + 
20AV 
Block 
20AV 
Block 
ST 
II 0AVB ST N - - - 130 20 1.0 130 5.5 
28 Muniappan 18/M 928092 4/2/07 9.10pm 
4/2/07 
5.10pm 4.00 - 3/G + - - N N N N - - - - 100 20 0.8 130 4.0 
29 Suresh 24/M 928708 13/2/07 10.15pm 
13/2/07 
6.00pm 4.15 - 1/W - - - N N N N N - - - 86 20 0.8 136 4.2 
30 Parvathi 35/F 928710 13/2/07 7.50pm 
13/2/07 
2.00pm 5.50 - 2/G - -  N N N N N - - - 86 20 0.8 130 4.0 
31 Laxmi 32/F 930109 19/2/07 11.30pm 
19/2/07 
6.15pm 5.15 - 5/P + +  SB SB SB N N N N - 90 30 1.0 135 4.8 
32 Padmini 35/F 930519 22/2/07 7.15pm 
22/2/07 
2.30pm 4.45 + 3/W - -  N N N N - - - - 96 28 0.8 130 4.0 
33 Revathi 32/F 931752 5/3/07 9.45pm 
5/3/07 
5.15pm 4.30 - 5/G - +  SB SB 
SB 
Tv 
SB 
Tv N N N N 100 30 1.0 130 4.9 
34 Vasu 20/M 933125 17/03.07 3.00am 
16/03/07 
10.00pm 5.00 - 5/G - -  SB SB SB SB SB N N - 112 28 0.8 135 4.0 
35 Radhika 37/F 933152 18/3/07 9.30pm 
18/3/07 
4.30pm 5.00 - 5/G - -  SAB SAB N N N - - - 90 26 0.8 129 4.0 
36 Thirumani 35/M 934953 29/3/07 4.40pm 
29/3/07 
1.00pm 3.40 - 3/G + -  SB SB N N N N - - 102 36 1.1 130 4.2 
37 Vinodhini 17/F 935153 1/4/07 11.40pm 
1/4/07 
7.30am 4.10 + 3/G + -  N N N N N - - - 108 20 0.8 129 3.5 
38 Anitha 18/F 935561 5/4/07 2.00pm 
5/4/07 
10.00am 4.00 - 3Ch + -  N N N N N - - - 110 24 1.0 135 3.9 
39 Vembu 26/F 935575 6/4/07 6.10pm 
6/4/07 
6.10am 12.00 - 4/G - +  VT - - - - - - - 120 30 1.1 135 5.5 
40 Malaiyappan 27/M 939757 28/4/07 12.45am 
27/4/07 
8.00pm 4.45 + 6/G - -  SB SB N N N - - - 86 22 1.0 130 3.8 
41 Sumathi 27/F 940069 11/5/07 5.10pm 
11/5/07 
1.10pm 4.00 - 10/G + -  N N N N N - - - 100 32 1.0 128 4.0 
42 Parthiban 18/M 940106 12/5/07 3.40pm 
12/507 
7.30am 8.10 - 5/G - -  SB SB SB N N N - - 132 28 0.8 134 4.2 
43 Suresh 26/M 942633 21/5/07 11.20pm 
21/5/07 
7.30pm 3.50 - 4/W - -  N N N N N - - - 118 32 1.0 130 4.5 
44 Chinnaraja 20/M 943445 29/5/07 9.00pm 
29/5/07 
7.00pm 2.00 - 5/G - - - Tv Tv Tv N N N - - 108 30 1.0 132 5.6 
45 Rekha 18/F 945012 10/6/07 8.55pm 
10/6/07 
2.10pm 6.45 - 5/P + - - SB SB SB ST ST N N - 110 32 1.0 128 4.0 
46 Bama 19/F 945249 13/6/07 4.15am 
12/6/07 
10.15pm 6.00 + 1 Ch - - - SAB SAB SAB N N N N - 96 22 0.8 130 4.2 
47 Usha 19/F 945716 17/6/07 11.00am 
17/6/07 
9.00am 2.00 - 5/G - + - SB SB SB SB N N N - 102 30 1.0 134 40 
48 Muthu 22/M 945828 18/06/07 3.00pm 
18/06/07 
9.30am 5.30 - 10/G + - - I 
0AVB I 0AVB I 0AVB N N N - - 132 24 0.8 132 4.2 
49 Sankari 18/F 946536 24/06/07 2.45am 
23/06/07 
11.00pm 3.45 - 1/W - - - N N N N N N - - 92 22 0.8 128 4.0 
50 Nithiya 19/F 947182 29/06/07 3.15pm 
29/06/07 
7.45am 7.30 - 5/G - + - Tv Tv Tv N N N N - 128 32 1.0 135 4.5 
51 Rajeswari 19/F 947199 30/06/07 11.10pm 
30.06.07 
11.00am 12.10 - 4/G - - - S Tv S Tv S Tv N N N N - 112 20 0.8 129 5.4 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ECG  MASTER CHART 
 
 
  
  
 
S. 
No. 
 
Name 
Ip.No. ECG 
No 
Rate/Rhythm 
Per/minute Axis 
‘P’ 
Wave 
PR in 
Sec QRS 
 
‘T’ 
 
STSEG QTC ‘U’ Impression 
I 56/Mt Sinus N N 0.165 N N N 0.38 N Sinus Bradycardia 
II 49/Mt  Sinus N N 0.16 N N N 0.35 N Sinus Bradycardia 
III 52/Mt Sinus N N 0.16 N N N 0.35 N Sinus Bradycardia 
IV 58/Mt Sinus N N 0.16 N N N 0.38 N Sinus Bradycardia 
V 60/Mt Sinus N N 0.16 N N N 0.38 N Sinus Bradycardia 
VI 60/Mt  Sinus N N 0.16 N N N 0.38 N Sinus Bradycardia 
VII 60/Mt Sinus N N 0.16 N N N 0.38 N Sinus Bradycardia 
1. Eswari 884194 
VIII 72/Mt Sinus N N 0.16 N N N 0.43 N Normal 
I 78/Mt  Sinus N N 0.12 N N ↓LII LIII Avf 0.48 N Ischemia 
II 78/Mt Sinus N N 0.12 N N ↓LII LIII Avf 0.42 N Normal 
III 82/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
IV 84/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
2. Seetha 885513 
V 84/Mt Sinus N N 0.12 N N N 0.42 N Normal 
I 88/Mt Sinus N N 0.12 N N N 0.42 N Normal 
II 82/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
III 90/Mt  Sinus N N 0.12 N N N 0.43 N Normal 
IV 88/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
3. Anitha 887013 
V 88/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
I 90/Mt  Sinus N N 0.16 N N N 0.44 N Normal 
II 88/Mt  Sinus N N 0.14 N N N 0.42 N Normal 
III 92/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
IV 86/Mt  Sinus N N 0.14 N N N 0.44 N Normal 
4. Annam 888003 
V 88/Mt  Sinus N N 0.14 N N N 0.42 N Normal 
I 76/Mt  Sinus N N 0.12 N 
ST↓ 
L3 
 v4 – 
V6 
↓AVF 
 V4-6 
0.43 N ST↓ 
II 78/Mt  Sinus N N 0.12 N 
ST↓ 
L3 
 AVF 
V4-6 0.43 N ST↓ 
III 71/Mt  Sinus N N 0.12 N 
ST↓ 
L3 
 v4 – 
V6 
↓AVF 
 V4-6 
0.43 N ST↓ 
IV 78/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
V 76/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
VI 79/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
5. Rama 
mirtha
m 
891016 
VII 80/Mt Sinus N N 0.12 N N N 0.43 N Normal 
I 80/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
II 78/Mt Sinus N N 0.14 N N N 0.44 N Normal 
III 88/Mt Sinus N N 0.12 N N N 0.44 N Normal 
6. Lalitha 891218 
IV 86/Mt Sinus N N 0.12 N N N 0.44 N Normal 
I 58/Mt Sinus N N 0.16 N N N 0.44 N SB 
II 54/Mt Sinus N N 0.16 N N N 0.43 N SB 
III 52/Mt Sinus N N 0.16 N N N 0.44 N SB 
IV 72/Mt Sinus N N 0.12 N N N 0.42 N Normal 
V 78/Mt Sinus N N 0.12 N N N 0.44 N Normal 
VI 80/Mt  Sinus N N 0.14 N N N 0.42 N Normal 
VII 78/Mt Sinus N N 0.12 N N N 0.42 N Normal 
7. Jeyapa
ul 
891312 
VIII 86/Mt Sinus N N 0.12 N N N 0.42 N Normal 
I 78/Mt Sinus N N 0.12 N N N 0.42 N Normal 
II 80/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
III 82/Mt Sinus N N 0.12 N N N 0.43 N Normal 
8. Rani 892034 
IV 86/Mt Sinus N N 0.12 N N N 0.42 N Normal 
  
  
 
I 58/Mt Sinus N N 0.36 N N N 0.40 N SB  I 0AVB 
II 56/Mt Sinus N N 0.32 N N N 0.40 N SB  with I 0AVB 
III 53/Mt  Sinus N N 0.36 N N N 0.36 N Normal 
IV 68/Mt Sinus N N 0.20 N N N 0.42 N Normal 
V 72/Mt Sinus N N 0.16 N N N 0.44 N Normal 
VI 78/Mt Sinus N N 0.16 N N N 0.43 N Normal 
9. Vijaya
kumar 
892939 
VII 78/Mt Sinus N N 0.16 N N N 0.44 N Normal 
I 78/Mt Sinus N N 0.12 N N N 0.42 N Normal 
II 80/Mt Sinus N N 0.14 N N N 0.42 N Normal 
III 76/Mt Sinus N N 0.12 N N N 0.43 N Normal 
10 Ilayara
ja 
894539 
IV 82/Mt Sinus N N 0.12 N N N 0.42 N Normal 
I 81/Mt Sinus N N 0.12 N N N 0.45 N Normal 
II 79/Mt Sinus N N 0.14 N N N 0.42 N Normal 
III 82/Mt Sinus N N 0.12 N N N 0.44 N Normal 
11 Kolaji
nathan 
895942 
IV 84/Mt Sinus N N 0.14 N N N 0.42 N Normal 
I 82/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
II 81/Mt  Sinus N N 0.16 N N N 0.41 N Normal 
III 78/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
IV 83/Mt Sinus N N 0.16 N N N 0.40 N Normal 
12. Raji 896239 
V 84/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
I 52/Mt  Sinus N N 0.24 N N N 0.42 N SB  with I 0AVB 
II 27/Mt  Sinus N N 0.28 N N N 0.40 N SB  with I 0AVB 
III 52/Mt Sinus N N 0.24 N N N 0.42 N SB  with I 0AVB 
IV 72/Mt  Sinus N N 0.20 N N N 0.44 N Normal 
V 76/Mt  Sinus N N 0.20 N N N 0.44 N Normal 
VI 88/Mt  Sinus N N 0.16 N N N 0.45 N Normal 
13 Murug
esan 
896450 
VII 86/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
I 58/Mt  Sinus N N 0.14 N N N 0.45 N Normal 
II 60/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
III 59/Mt  Sinus N N 0.12 N N N 0.40 N SB 
IV 60/Mt  Sinus N N 0.14 N N N 0.40 N SB 
V 72/Mt  Sinus N N 0.14 N N N 0.41 N SB 
VI 78/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
VII 82/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
14 Kokila 918451 
VIII 80/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
I 78/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
II 84/Mt  Sinus N N 0.16 N N N 0.42 N Normal 
III 83/Mt  Sinus N N 0.16 N N N 0.42 N Normal 
IV 86/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
15 Joyce 
mary 
918469 
V 92/Mt  Sinus N N 0.12 N N N 0.41 N Normal 
I 82/Mt  Sinus N N 0.16 N N N 038 N Normal 
II 86/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
III 83/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
IV 82/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
16 Malarv
izhi 
918654 
V 81/Mt  Sinus N N 0.16 N N N 0.42 N Normal 
I 58/Mt  Sinus N N 0.12 N N N 0.36 N SB 
II 52/Mt  Sinus N N 0.12 N N N 0.38 N SB 
III 47/Mt  Sinus N N 0.12 N N N 0.39 N SB 
IV 52/Mt  Sinus N N 0.12 N N N 0.40 N SB 
V 68/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
VI 72/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
VII 78/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
17 Kalaiy
arasu 
919093 
VIII 80/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
I 52/Mt  Sinus N N 0.14 N N N 0.40 N SB 
II 58/Mt  Sinus N N 0.14 N N N 0.40 N SB 
III 68/Mt  Sinus N N 0.16 N N N 0.44 N Normal 
IV 72/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
V 88/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
18 Malika 919506 
VI 82/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
I 48/Mt  Sinus N N 0.16 N N N 0.36 N SB 19 Savithri 920632 
II 52/Mt  Sinus N N 0.16 N N N 0.36 N SB 
  
  
III 52/Mt  Sinus N N 0.16 N N N 0.36 N SB 
IV 46/Mt  Sinus N N 0.16 N N N 0.36 N SB 
V 72/Mt  Sinus N N 0.14 N N N 0.40 N Normal 
VI 78/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
VII 80/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
I 100/MtSinus N N 0.16 N N N 0.50 N ST 
II 102/MtSinus N N 0.16 N N N 0.50 N ST 
III 100/MtSinus N N 0.16 N N N 0.50 N ST 
IV 120/MtSinus N N 0.20 N N N 0.56 N ST 
V 96/Mt  Sinus N N 0.12 N N N 0.45 N Normal 
VI 92/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
VII 97/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
20 Sathiy
araj 
921120 
VIII 90/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
I 90/Mt  Sinus N N 0.14 N N N 0.44 N Normal 
II 88/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
III 92/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
IV 92/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
21 Rames
h 
921246 
V 91/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
I 91/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
II 86/Mt  Sinus N N 0.14 N N N 0.42 N Normal 
III 82/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
IV 88/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
22 Parvat
hi 
921887 
V 89/Mt  Sinus N N 0.14 N N N 0.40 N Normal 
I 72/Mt  Sinus N N 0.17 N N N 0.40 N Normal 
II 76/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
III 80/Mt  Sinus N N 0.14 N N N 0.44 N Normal 
IV 82/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
23 Malarv
izhi 
921939 
V 80/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
I 73/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
II 72/Mt  Sinus N N 0.16 N N N 0.41 N Normal 
III 78/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
IV 89/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
24 Subhia
h 
922800 
V 86/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
I 82/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
II 88/Mt  Sinus N N 0.16 N N N 0.42 N Normal 
III 92/Mt  Sinus N N 0.14 N N N 0.40 N Normal 
IV 88/Mt  Sinus N N 0.14 N N N 0.40 N Normal 
25 Ranjith
a 
922945 
V 88/Mt  Sinus N N 0.14 N N N 0.40 N Normal 
I 82/Mt  Sinus N N 0.16 N N N 0.38 N Normal 
II 81/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
III 88/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
IV 89/Mt  Sinus N N 0.16 N N N 0.42 N Normal 
26 Chitra 923328 
V 92/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
I 92/Mt  Sinus N N 0.14 N N N 0.48 N II 0AVB 
II 98/Mt  Sinus N N 0.14 N N N 0.48 N II 0AVB 
III 102/MtSinus N N 0.12 N N N 0.50 N ST with  II 0AVB 
IV 98/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
V 92/Mt  Sinus N N 0.12 N N N 0.46 N Normal 
VI 91/Mt  Sinus N N 0.12 N N N 0.46 N Normal 
27 Vanak
amudi 
923419 
VII 92/Mt  Sinus N N 0.12 N N N 0.46 N Normal 
I 82/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
II 84/Mt  Sinus N N 0.16 N N N 0.42 N Normal 
III 88/Mt  Sinus N N 0.16 N N N 0.42 N Normal 
IV 87/Mt  Sinus N N 0.16 N N N 0.42 N Normal 
28 Munia
ppan 
928092 
V 86/Mt  Sinus N N 0.16 N N N 0.42 N Normal 
I 88/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
II 89/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
III 91/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
IV 82/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
29 Suresh 928708 
V 88/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
I 78/Mt  Sinus N N 0.16 N N N 0.42 N Normal 
II 85/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
III 86/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
IV 88/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
30 Parvat
hi 
928710 
V 87/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
  
  
I 52/Mt  Sinus N N 0.16 N N N 0.48 N SB 
II 58/Mt  Sinus N N 0.16 N N N 0.46 N SB 
III 60/Mt  Sinus N N 0.16 N N N 0.46 N SB 
IV 72/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
V 78/Mt  Sinus N N 0.14 N N N 0.44 N Normal 
VI 76/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
31 Laxmi 930109 
VII 82/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
I 78/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
II 81/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
III 80/Mt  Sinus N N 0.12 N N N 0.43 N Normal 
IV 89/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
32 Padmi
ni 
930519 
V 81/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
I 60/Mt  Sinus N N 0.14 N N N 0.40 N SB 
II 58/Mt  Sinus N N 0.14 N N N 0.42 N SB 
III 58/Mt  Sinus N N 0.16 N T↓ LIII   V1-6 N 0.40 N 
SB With  
T Inversion 
IV 56/Mt  Sinus N N 0.16 N T↓ L3 V1-6 N 0.41 N 
SB With  
T Inversion 
V 68/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
VI 72/Mt  Sinus N N 0.16 N N N 0.42 N Normal 
VII 72/Mt  Sinus N N 0.16 N N N 0.44 N Normal 
33 Revath
i 
931752 
VIII 88/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
I 59/Mt  Sinus N N 0.14 N N N 0.42 N SB 
II 58/Mt  Sinus N N 0.16 N N N 0.41 N SB 
III 60/Mt  Sinus N N 0.16 N N N 0.42 N SB 
IV 60/Mt  Sinus N N 0.16 N N N 0.42 N SB 
V 60/Mt  Sinus N N 0.16 N N N 0.44 N SB 
VI 68/Mt  Sinus N N 0.12 N N N 0.43 N Normal 
VII 78/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
VIII 82/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
34 Vasu 933125 
IX 81/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
I 80/Mt  Sinus N N 0.16 N N N 0.40 N SAB 
II 82/Mt  Sinus N N 0.16 N N N 0.42 N SAB 
III 84/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
IV 86/Mt  Sinus N N 0.16 N N N 0.44 N Normal 
V 88/Mt  Sinus N N 0.16 N N N 0.44 N Normal 
35 Radhik
a 
933152 
VI 87/Mt  Sinus N N 0.16 N N N 0.44 N Normal 
I 58/Mt  Sinus N N 0.12 N N N 0.40 N SB 
II 60/Mt  Sinus N N 0.16 N N N 0.41 N SB 
III 68/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
IV 72/Mt  Sinus N N 0.16 N N N 0.44 N Normal 
V 78/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
VI 79/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
36 Thiru
mani 
934953 
VII 78/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
I 78/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
II 76/Mt  Sinus N N 0.14 N N N 0.43 N Normal 
III 78/Mt  Sinus N N 0.14 N N N 0.42 N Normal 
IV 82/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
37 Vinod
hini 
935153 
V 80/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
I 72/Mt  Sinus N N 0.12 N N N 0.38 N Normal 
II 79/Mt  Sinus N N 0.14 N N N 0.40 N Normal 
III 78/Mt  Sinus N N 0.14 N N N 0.38 N Normal 
IV 82/Mt  Sinus N N 0.14 N N N 0.39 N Normal 
38 Anitha 935561 
V 82/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
39 Vembu 935575 
I 106  Ventricular - 
Absen
t - 
Abn
orm
al 
Abnor
mal - 
Abse
nt N 
IDIO 
Ventricular 
Tachycardia 
I 59/Mt  Sinus N N 0.14 N N N 0.42 N SB 
II 60/Mt  Sinus N N 0.14 N N N 0.42 N SB 
III 72/Mt  Sinus N N 0.16 N N N 0.44 N Normal 
IV 80/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
V 80/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
40 Malaiy
appan 
939757 
VI 87/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
I 82/Mt  Sinus N N 0.12 N N N 0.40 N Normal 
II 84/Mt  Sinus N N 0.14 N N N 0.42 N Normal 
41 Sumat
hi 
940069 
III 83/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
  
  
IV 88/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
V 87/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
I 58/Mt  Sinus N N 0.16 N N N 0.38 N SB 
II 60/Mt  Sinus N N 0.16 N N N 0.40 N SB 
III 60/Mt  Sinus N N 0.12 N N N 0.40 N SB 
IV 68/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
V 78/Mt  Sinus N N 0.14 N N N 0.44 N Normal 
VI 75/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
42 Parthib
an 
940106 
VII 78/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
I 78/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
II 86/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
III 92/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
IV 90/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
43 Suresh 942633 
V 91/Mt  Sinus N N 0.16 N N N 0.40 N Normal 
I 82/Mt  Sinus N N 0.12 N N N 0.42 N N↑↓  Inversion 
II 80/Mt  Sinus N N 0.12 N N N 0.43 N N↑↓  Inversion 
III 81/Mt  Sinus N N 0.12 N N N 0.42 N N↑↓  Inversion 
IV 82/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
V 84/Mt  Sinus N N 0.12 N N N 0.44 N Normal 
VI 85/Mt  Sinus N N 0.12 N N N 0.42 N Normal 
44 Chinna
raja 
943445 
VII 81/Mt  Sinus N N 0.14 N N N 0.42 N Normal 
I 58/Mt  Sinus N N 0.12 N N N 0.40 N SB 
II 60 /Mt  Sinus N N 0.12 N N N 0.40 N SB 
III 60 /Mt  Sinus N N 0.12 N N N 0.40 N SB 
IV 115/Mt Sinus N N 0.12 N ↓L2, V4-V6 
↓L2,V4-
V6 
0.56 N 
ST with  
rate related 
ST –T 
Changes 
V 108/Mt  Sinus N N 0.12 N 
L3,  
V24-V6 
↓V4-V6 0.50 N ST with  ST – T Changes 
VI 98/Mt  Sinus N N 0.14 N N N 0.44 N Normal 
VII 92/Mt  Sinus N N 0.14 N N N 0.40 N Normal 
45 Rekha 945012 
VIII 91/Mt  Sinus N N 0.14 N N N 0.42 N Normal 
I 98 /Mt  Sinus N N 0.12 N N N 0.48 N SAB 
II 98 /Mt  Sinus N N 0.12 N N N 0.48 N SAB 
III 96 /Mt  Sinus N N 0.12 N N N 0.49 N SAB 
IV 92 /Mt  Sinus N N 0.12 N N N 0.44 N Normal 
V 91 /Mt  Sinus N N 0.12 N N N 0.44 N Normal 
VI 92 /Mt  Sinus N N 0.12 N N N 0.42 N Normal 
46 Bama 945249 
VII 91 /Mt  Sinus N N 0.12 N N N 0.44 N Normal 
I 60 /Mt  Sinus N N 0.14 N N N 0.45 N SB 
II 60 /Mt  Sinus N N 0.14 N N N 0.44 N SB 
III 58 /Mt  Sinus N N 0.12 N N N 0.42 N SB 
IV 60 /Mt  Sinus N N 0.12 N N N 0.40 N SB 
V 72 /Mt  Sinus N N 0.12 N N N 0.40 N Normal 
VI 70 /Mt  Sinus N N 0.12 N N N 0.40 N Normal 
47 Usha 945716 
VII 81 /Mt  Sinus N N 0.12 N N N 0.40 N Normal 
I 78/Mt  Sinus N N 0.14 N N N 0.40 N Normal 
II 91 /Mt  Sinus N N 0.12 N N N 0.40 N Normal 
III 88 /Mt  Sinus N N 0.12 N N N 0.41 N Normal 
48 Muthu 945828 
IV 87 /Mt  Sinus N N 0.12 N N N 0.40 N Normal 
49 Sankari 946536 I 70 /Mt  Sinus N N 0.24 N N N 0.40 N I 0AVB 
  
  
II 68 /Mt  Sinus N N 0.24 N N N 0.42 N I 0AVB 
III 71 /Mt  Sinus N N 0.24 N N N 0.40 N I 0AVB 
IV 72 /Mt  Sinus N N 0.18 N N N 0.41 N Normal 
V 78 /Mt  Sinus N N 0.18 N N N 0.41 N Normal 
VI 76 /Mt  Sinus N N 0.18 N N N 0.40 N Normal 
I 78 /Mt  Sinus N N 0.12 N N ↓V3-V6 0.42 N ‘T’  Inversion 
II 76 /Mt  Sinus N N 0.12 N N ↓V3-V6 0.42 N ‘T’  Inversion 
III 77 /Mt  Sinus N N 0.12 N N ↓V3-V6 0.42 N ‘T’  Inversion 
IV 78 /Mt  Sinus N N 0.12 N N N 0.43 N Normal 
V 80 /Mt  Sinus N N 0.14 N N N 0.40 N Normal 
VI 81 /Mt  Sinus N N 0.14 N N N 0.40 N Normal 
50 Nithiya 947182 
VII 80 /Mt  Sinus N N 0.12 N N N 0.40 N Normal 
I 72 /Mt  Sinus N N 0.14 N N ↓L2, 3, avf 0.44 N 
ST 
Depression 
II 78 /Mt  Sinus N N 0.14 N N ↓L2, 3, avf 0.44 N 
ST 
Depression 
III 80 /Mt  Sinus N N 0.12 N N ↓L2, 3, avf 0.44 N 
ST 
Depression 
IV 81 /Mt  Sinus N N 0.12 N N N 0.42 N Normal 
V 80 /Mt  Sinus N N 0.12 N N N 0.40 N Normal 
VI 82 /Mt  Sinus N N 0.12 N N N 0.40 N Normal 
51 Rajes
wari 
947199 
VII 81 /Mt  Sinus N N 0.12 N N N 0.40 N Normal 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
ABBREVIATIONS 
 
  
  
ABBREVIATIONS 
 
S.No.  - Patient Number 
SW  - Stomach Wash 
V  - Vomiting 
Pa  - Palpitation 
O  - Others 
B S  - Blood Sugar 
B U  - Blood Urea 
S C  - Serum Creatinine 
S Na  - Serum Sodium 
S K  - Serum Potassium 
S T  - Sinus Tachycardia 
N  - Normal 
G  - Grounded 
P  - Paste 
Ch  - Chewed 
W  - Whole 
T↓  - T Inversion 
I0AVB - First Degree AtrioVentricular Block 
II0AVB - Second Degree AtrioVentricular Block 
VT  - Ventricular Tachycardia 
ST↓  - ST  Depression 
SAB  - Sino Atrial Block 
Axis  - Normal (+40 to +60) 
SB  - Sinus Bradycardia 
 
